Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy with Dexrazoxane for Osteosarcoma
NCT00019864Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Mar 2000
- Primary completion
- Dec 2006
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, doxorubicin, methotrexate in osteosarcoma (OS), sponsored by National Cancer Institute. Started Mar 2000; status: terminated.
02
Drugs
cisplatindoxorubicinmethotrexate
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT00019864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00019864.